S Mahrane^1,2*, H Riad¹ and Z Ghechi^1,2

¹Central Biology Laboratory, CHU Hussein Dey, Algiers, Algeria

*Corresponding Author: S Mahrane, Central Biology Laboratory, CHU Hussein Dey, Algiers, Algeria.

Received: March 11, 2022; Published: January 12, 2023

Abstract

Objective: The objective of this work is to determine the carriage rate of Streptococcus b in pregnant women in the last trimester, to specify the serotypes, to assess the antibiotic sensitivity of the carried strains and to determine the support of the resistance to macrolides and aminoglycosides.

Material and Methods: This was a prospective study from March 1, 2015 to September 30, 2015, which included 389 of patients consulting at the Gynecology and Obstetrics Department, Nafissa Hamoud university hospital Hussein Dey Algiers, Algeria, it has been carried out according to the recommendations of the CDC.

The harvested strains benefited from a study of antibiotic sensitivity, a search of resistance gene to macrolide (ermA, erm B and Mef A) and aminoglycosides aad6 and Aph3 and serotyping were detected by multiplex PCR.

Results: The carriage rate found was 22.6%. All strains were sensitive to betalactamines, 50% were resistant to macrolides and 25% to aminoglycosides. A predominance of the ermb gene and the aph3 gene was found; with predominance of the serotype Ib.

Conclusion: The carriage rate of streptococcus b is highly significative represented mainly by serotype Ib, strains are sensitive to betalactamines but 50% proved resistant to macrolides, prophylactic measures must be instituted to prevent transmission.

Keywords: Streptococcus agalactiae; Gynecology; Serotypes

References

1. Eickhoff TC., et al. “Neonatal Sepsis and Other Infections Due to Group B Beta-Hemolytic Streptococci”. The New England Journal of Medicine 24 (2019): 1221‑1228.
2. texte IPA du. Annales de l’Institut Pasteur : Journal de Microbiologie / publiées sous le patronage de M. Pasteur par E. Duclaux Gallica (1887).
3. Ohlsson Arne and Vibhuti SS. “Intrapartum antibiotics for known maternal Group B streptococcal colonization”. (2019).
4. Barcaite E., et al. “Prevalence of maternal group B streptococcal colonisation in European countries”. Acta Obstetricia et Gynecologica Scandinavica 3 (2019): 260‑271.
5. Dillon HC., et al. “Anorectal and Vaginal Carriage of Group B Streptococci During Pregnancy”. Journal of Infectious Disease6 (1982): 794‑799.
6. van der Mee-Marquet N., et al. “Genetic diversity of Streptococcus agalactiae strains and density of vaginal carriage”. Journal of Medical Microbiology2 (2009): 169‑173.
7. Baker Carol J. Group B Streptococcal Infections - ScienceDirect (2019).
8. Stoll BJ and Schuchat A. “Maternal carriage of group B streptococci in developing countries”. Pediatric Infectious Disease Journal 6 (1998): 499.
9. Hraoui M., et al. “Macrolide and tetracycline resistance in clinical strains of Streptococcus agalactiae isolated in Tunisia”. Journal of Medical Microbiology 61 (2012): 1109‑11
10. Lopardo HA., et al. “Six-Month Multicenter Study on Invasive Infections Due to Group B Streptococci in Argentina”. Journal of Clinical Microbiology10 (2003): 4688‑4694.
11. Imperi M., et al. “A multiplex PCR assay for the direct identification of the capsular type (Ia to IX) of Streptococcus agalactiae”. Journal of Microbiological Methods2 (2010): 212‑214.
12. Ait AA and Hamidechi MA. “Incidence du streptocoque du groupe b (sgb) chez les nouveau-nés nés à Constantine (Algérie) et dans deux de ses banlieues. Intérêt de la détermination des sérotypes”. Médecine et Maladies Infectieuses8 (2008): 417‑21.
13. M Mahmoud., et al. “Dépistage de streptocoque du groupe b au cours du troisième trimestre de grossesse au chu Hassan II de Fès”. Revue Tunisienne D'infectiologie 1 (2001): 12‑15.
14. Bassir A., et al. “Portage vaginal du streptocoque du groupe B chez la femme enceinte au niveau de la région de Marrakech”. Pan African Medical Journal 23 (2016).
15. Jerbi M., et al. “Facteurs de risque du portage du streptocoque du groupe B chez la femme enceinte à terme: étude prospective à propos de 294 cas”. Gynécologie Obstétrique et fertilité4 (2007): 312‑316.
16. Kwatra G., et al. “Prevalence of maternal colonisation with group B streptococcus: a systematic review and meta-analysis”. Lancet Infectious Disease9 (2016): 1076‑84.
17. Alemseged G., et al. “Isolation and anti-microbial susceptibility pattern of group B Streptococcus among pregnant women attending antenatal clinics in Ayder Referral Hospital and Mekelle Health Center, Mekelle, Northern Ethiopia”. BMC Research Notes1 (2015).
18. Morita T., et al. “Evaluation of chromID strepto B as a screening media for Streptococcus agalactiae”. BMC Infectious Disease1 (2014).
19. Xie Y., et al. “Occurrence and detection method evaluation of group B streptococcus from prenatal vaginal specimen in Northwest China”. Diagnostic Pathology1 (2016).
20. Infections néonatales à Streptococcus agalactiae: épidémiologie, physiopathologie et diagnostic biologique calameo.com.
21. Bidgani S., et al. “Comparison of group B streptococci colonization in vaginal and rectal specimens by culture method and polymerase chain reaction technique”. Journal of the Chinese Medical Association 3 (2016): 141‑145.
22. Khan MA., et al. “Maternal colonization of group B streptococcus: prevalence, associated factors and antimicrobial resistance”. Annals of Saudi Medicine6 (2015): 423‑427.
23. Joachim A., et al. “Maternal and neonatal colonisation of group B streptococcus at Muhimbili National Hospital in Dar es Salaam, Tanzania: prevalence, risk factors and antimicrobial resistance”. BMC Public Health1 (2009): 437.
24. Garland SM., et al. “Antimicrobial resistance in group B streptococcus: the Australian experience”. Journal of Medical Microbiology2 (2011): 230‑235.
25. Bergal A., et al. “Molecular epidemiology and distribution of serotypes, genotypes, and antibiotic resistance genes of Streptococcus agalactiae clinical isolates from Guelma, Algeria and Marseille, France”. European Journal of Clinical Microbiology and Infectious Diseases 12 (2015): 2339‑2348.
26. Betriu C., et al. “Antibiotic resistance and penicillin tolerance in clinical isolates of group B streptococci”. Antimicrobial Agents and Chemotherapy9 (1994): 2183‑2186.
27. Kimura K., et al. “First Molecular Characterization of Group B Streptococci with Reduced Penicillin Susceptibility”. Antimicrobial Agents and Chemotherapy8 (2008): 2890‑2897.
28. Honderlick P., et al. “Bilan bactériologique de six ans de dépistage du streptocoque de groupe B (SGB) au cours du dernier trimestre de la grossesse”. Pathologie Biologie2 (2010): 144‑146.
29. Brigtsen AK., et al. “Comparison of PCR and serotyping of Group B Streptococcus in pregnant women: The Oslo GBS-study”. Journal of Microbiological Methods 108 (2015): 31‑3
30. Suhaimi MES., et al. “Characterization of a Group B Streptococcus infection based on the demographics, serotypes, antimicrobial susceptibility and genotypes of selected isolates from sterile and non-sterile isolation sites in three major hospitals in Malaysia”. Journal of Infectious Public Health 1 (2017): 14‑21.
31. Wang P., et al. “Serotype distribution, antimicrobial resistance, and molecular characterization of invasive group B Streptococcus isolates recovered from Chinese neonates”. International Journal of Infectious Diseases 37 (2015): 115‑11
32. del Pilar Crespo-Ortiz M., et al. “Emerging trends in invasive and noninvasive isolates of Streptococcus agalactiae in a Latin American hospital: a 17-year study”. BMC Infectious Diseases 1 (2014): 428.
33. Bolukaoto JY., et al. “Antibiotic resistance of Streptococcus agalactiae isolated from pregnant women in Garankuwa, South Africa”. BMC Research Notes1 (2015): 364.
34. Shabayek SAAE., et al. “Vaginal carriage and antibiotic susceptibility profile of group B Streptococcus during late pregnancy in Ismailia, Egypt”. Journal of Infectious Public Health2 (2009): 86‑90.
35. Florindo C., et al. “Epidemiological surveillance of colonising group B Streptococcus epidemiology in the Lisbon and Tagus Valley regions, Portugal (2005 to 2012): emergence of a new epidemic type IV/clonal complex 17 clone”. Eurosurveillance 23 (2014): 20825.
36. Gherardi G., et al. “Molecular Epidemiology and Distribution of Serotypes, Surface Proteins, and Antibiotic Resistance among Group B Streptococci in Italy”. Journal of Clinical Microbiology 45.9 (2007): 2909‑29
37. Dutra VG., et al. “Streptococcus agalactiae in Brazil: serotype distribution, virulence determinants and antimicrobial susceptibility”. BMC Infectious Disease 1 (2014).
38. Otaguiri ES., et al. “Commensal Streptococcus agalactiae isolated from patients seen at University Hospital of Londrina, Paraná, Brazil: capsular types, genotyping, antimicrobial susceptibility and virulence determinants”. BMC Microbiology 13 (2013): 297.
39. Sadeh M., et al. “Molecular characterization of Streptococcus agalactiae isolates from pregnant and non-pregnant women at Yazd University Hospital, Iran”. Jundishapur Journal of Microbiology 2 (2016).

Citation

Citation: S Mahrane., et al. “Prevalence, Sensitivity to Antibiotics and Serotypes of Streptococcus b Carriage in Pregnant Women in Algiers". Acta Scientific Microbiology 6.2 (2023): 43-48.

Copyright

Copyright: © 2022 S Mahrane., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.